Gender Differences in Drug Use among Individuals Under Arrest.
Gender Differences in Drug Use among Individuals Under Arrest.
复制标题
被捕者吸毒的性别差异。
DOI：
10.1080/14659891.2022.2070872
复制
发表时间：
2023
影响因子：
0.8
通讯作者：
Amaratunga,Piyadarsha
中科院分区：
文献类型：
--
作者：
Weller,BridgetE;Magura,Stephen;Smith,DawnR;Saxton,MatthewM;Amaratunga,Piyadarsha
背景通过对被逮捕的个人进行药物测试进行药物监测提供了在地理区域内检测药物使用模式的机会。然而，在对刑事司法人口的大规模监测工作中，妇女被忽略了。本研究的目的是检查是否存在性别差异，在一个美国收集的口服液表明药物使用jails.MethodsThe研究分析了在2019-2020年收集的数据从个人被捕（N = 191）。24%的样本被确定为女性。收集口腔液标本，然后用酶联免疫吸附试验和液相色谱/串联质谱法进行分析。Logit回归模型检查性别difference.ResultsWomen更有可能测试阳性甲基苯丙胺比男性（41%比22%，OR = 0.42，95%CI 0.21-0.84）。其他物质（大麻，可卡因和阿片类药物），药物的合法性，或整体药物use.ConclusionsBecause国家药物滥用研究所的目的是促进健康公平，未来的药物监测在刑事司法人口应采用抽样方法代表妇女和男子的性别差异没有发现。这项研究将确定可能的基于性别的吸毒模式，并为基于性别的政策和临床实践提供信息，以预防和治疗药物滥用。
BackgroundDrug monitoring by drug testing of individuals under arrest provides an opportunity to detect drug use patterns within geographic areas. However, women have been omitted from large-scale monitoring efforts in criminal justice populations. The purpose of this study was to examine whether gender differences exist in drug use indicated by oral fluid collected in one U.S. jail.MethodsThe study analyzed data collected in 2019–2020 from individuals under arrest (N = 191). Twenty-four percent of the sample identified as female. Oral fluid specimens were collected and then analyzed with enzyme-linked immunosorbent assay and liquid chromatography/tandem mass spectrometry. Logit regression models examined gender differences.ResultsWomen were more likely to test positive for methamphetamines than men (41% versus 22%, OR = 0.42, 95% CI 0.21–0.84). Significant gender differences were not found for other substances (marijuana, cocaine, and opioids), legality of drugs, or overall drug use.ConclusionsBecause the National Institute on Drug Abuse aims to promote health equity, future drug monitoring in criminal justice populations should employ sampling approaches representing both women and men. This research would identify possible gender-based patterns of drug use and inform gender-based policies and clinical practices to prevent and treat drug misuse.